Form D · Biotechnology

LUREX BIO, INC

Fort Lauderdale, FL · CIK 0002108090

Offering snapshot reported Aug 31, 2026 · SEC filing

Reported sold
$150K
Indefinite offering
Investors reported
3
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jan 22, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$75K$150KFeb 5, 2026: $50,000.00Feb 5, 2026Aug 31, 2026: $150,000.00Aug 31, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$50,000 → $150,000
  • Reported investors1 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 31, 2026Amendment$150,000$100,000vs Feb 5, 20263SEC filing
Feb 5, 2026Initial$50,000No comparison1SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-572498

Source: Form D, filed Aug 31, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Clark Promoter
Horace Lanier, Iii Director, Executive
Dr Fred Mc Call Perez Executive
George Sens Executive
Mark Shumate Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
501 East Las Olas Blvd., Suite 300
Fort Lauderdale, FL, 33301
Phone: 8555873924